Related Experiment Video
Updated: Feb 25, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Structural and dynamic insights into agonist recognition and function of the thromboxane A2 receptor
Pawel Krawinski1, Donna Matzov2, Aoife Ryder1
1School of Medicine and School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland.
Researchers determined the structure of the thromboxane A2 receptor (TP) bound to Gq. This reveals a unique activation mechanism and provides insights into drug design and inherited disorders.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- The thromboxane A2 receptor (TP) is crucial for blood clotting and muscle contraction.
- Its endogenous ligand, thromboxane A2 (TXA2), has a very short half-life, complicating structural studies.
- Understanding TP structure and activation is vital for therapeutic development.
Purpose of the Study:
- To determine the structure of the TP in complex with Gq.
- To elucidate the unique activation mechanism of the TP.
- To provide insights into ligand binding and rational drug design.
Main Methods:
- X-ray crystallography to determine TP-Gq complex structures.
- Functional assays and mutational analysis.
- Molecular dynamics (MD) simulations and docking.
Main Results:
- Novel structures of the TP-Gq complex were resolved using synthetic agonists.
- A unique activation switch distinct from typical class A GPCRs was identified.
- A ligand entry pathway through a membrane-embedded molecular gate was revealed.
Conclusions:
- The study elucidates the TP activation mechanism and ligand binding.
- Findings aid in the rational design of TP-targeting compounds.
- Mechanistic insights into TP-related inherited disorders are provided.
More Related Videos
07:13Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
Related Concept Videos
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...